ScreenerHero

WINTWindtree Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · windtreetx.com
0.0002USD-81.82%Mkt Cap: 6741 $P/E: 0.00

Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap6.74K $
Enterprise Value3.29M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.79M $
Revenue/Share—
Last Price0.0002 USD
Fiscal Year EndDec 2024
MR QuarterSep 2025
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)-0.00
PEG—
EV/EBITDA-0.21
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)29.62
EPS (Forward)-2.13
52W Range
0.00010% of range0.6500
52W High0.6500 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-17.88%
ROA-6.41%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.40M $
CapEx (TTM)12.00K $
FCF Margin—
FCF Yield-350736.15%
Net Debt3.28M $
Net Debt/EBITDA-0.21
Balance Sheet
Debt/Equity0.18
Current Ratio0.33
Quick Ratio0.01
Book Value/Sh-0.3450 USD
Cash/Share0.0060 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateApr 29, 2020
Splits
Last Split1:50
Split DateFeb 21, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.33.71M
Float33.71M
Insiders0.00%
Institutions0.02%
Short Interest
Short Ratio0.1d
Short % Float6.25%
Short % Out.6.25%
Shares Short1.79M
Short (prev mo.)561.82K
Technical
SMA 500.0094 (-97.9%)
SMA 2000.0202 (-99.0%)
Beta1.61
S&P 52W Chg18.16%
Avg Vol (30d)17.62K
Avg Vol (10d)13.44K
Technical Indicators
RSI (14)28.8
MACD-0.0035
MACD Signal-0.0037
MACD Hist.+0.0003
BB Upper0.0150 USD
BB Middle0.0035 USD
BB Lower-0.0080 USD
BB Width654.47%
ATR (14)0.0013 USD
Vol Ratio (20d)0.57x